A tale of two trials of HAART interruption.
D017088:AIDS-Related Opportunistic Infections / Q000276:immunology*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008198:Lymph Nodes / Q000821:virology
D019380:Anti-HIV Agents; D007376:Interleukin-2